3.4.2. Vasodilator Drugs Flashcards
Purpose of vasodilators acting on arteries
arteries → reduce peripheral resistance (greater blood flow)
Purpose of vasodilators acting on veins
veins → increase capacitance (larger volume stored in venous system)
Purpose of vasodilators acting on coronary arteries
CORONARY arteries → improve cardiac blood flow
Propranolol, Sotalol
β1 & β2-adrenoceptor antagonists = Propranolol, Sotalol
metoprolol, Atenolol
β1-adrenoceptor selective antagonists = metoprolol, Atenolol,
Labetalol, Carvedilol
α1- & β-adrenoceptor antagonists = Labetalol, Carvedilol
Norepinephrine depletion drugs
Guanadrel, Reserpine
α2A-adrenoceptor agonists
Clonidine, Guanabenz, Guanfacine
fenoldopam
Dopamine D1 receptor agonists
Drug types acting through autonomic nervous system
ACE inhibitors
ARBs (Angiotensin Receptor Blockers)
Aldosterone receptor antagonists
Renin inhibitors
Captopril
ACE inhibitor
Losartan
ARB
Spironolactone and Eplerenone
Aldosterone receptor antagonists
Aliskiren
Renin inhibitor
MOA for Guanadrel
This is an exogenous false neurotransmitter that is accumulated, stored, and released like NE but is inactive at adrenergic receptors. Basically kicks out NE and takes its place.
- NET actively transports guanadrel into adrenergic neuronal storage vesicles.
- NE is displaced, resulting in specific inhibition of peripheral post-ganglionic adrenergic neurons
Adverse effects for Guanadrel
- effector cells become supersensitive to NE during adrenergic neuron blockade. This response is similar to that produced by postganglionic sympathetic denervation.
MOA for Reserpine
- binds tightly to adrenergic storage vesicles in central
and peripheral adrenergic neurons and remains bound for prolonged period of time - the vesicular catecholamine transporter that facilitates vesicular storage is inhibited
- thus, nerve endings
lose their capacity to concentrate and store NE and dopamine
Adverse effects for reserpine
- sympathetic dysfunction and antihypertensive effects observed in reserpine-induced depletion of biogenic amines, so central and peripheral effects likely contribute to these effects
- Recovery of sympathetic function requires synthesis of new
storage vesicles, which takes days to weeks after discontinuation of the drug
What are our Centrally-acting sympatholytic agents
Clonidine
Guanabenz
Guanfacine
MOA for Centrally acting sympatholytic agents
- α2A adrenergic receptors in the brainstem are stimulated
- sympathetic outflow from the CNS is reduced
- plasma NE concentrations decrease (direct relationship w/sympathetic activity)
Side effects for centrally acting sympatholytic agents
- at HIGHER doses, α2B receptors on vascular smooth muscle can be activated, inducing vasoconstriction
- loss of therapeutic effect observed at high doses
What are the following drugs examples of?
Clonidine
Guanabenz
Guanfacine
Centrally-acting sympatholytic agents
When do we use Hydralazine?
Clin Use: Severe HTN, CHF, HTN in pregnancy w/ methyldopa; frequently coadministered with B-blockers
MOA for Hydralazine
Increase cGMP → smooth muscle relaxation; vasodilates arterioles more than veins; afterload reduction
It seems to prevent the development of nitrate tolerance, perhaps by inhibiting vascular superoxide production
Side Effects for Hydralazine
- reflex-related increases in HR
- cardiac contractility
- Lupus-like syndrome
- fluid retention
Hydralazine is contraindicated in who?
contraindicated in patients with both hypertension and coronary artery disease
MOA for Minoxidil
K+ channel OPENER
- metabolized to the active metabolite minoxidil sulfate that activates the ATP-modulated K+ channel
- channel opening causes hyperpolarization and relaxation (mainly in arteriolar smooth muscle, little effect on veins)